These mechanisms suggest that TG may alleviate RA by enriching butyrate-producing microbiota, reducing Prevotella, and suppressing inflammatory pathways (NF-κB/STAT3) and cytokines (IL-6, TNF-α, IL-17). This evidence concerns the gene IL17A and rheumatoid arthritis.